ImmunologybioRxiv
B cells engineered to express pathogen-specific antibodies using CRISPR/Cas9 protect against infection
H. F. Moffett, C. K. Harms, K. S. Fitzpatrick…·J. J. Taylor
This study uses CRISPR/Cas9 to engineer B cells with pathogen-specific antibodies, providing durable protection against RSV in immunocompromised hosts.